RA CAPITAL MANAGEMENT, L.P. Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$3.8T
Holdings
88
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (88 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A/S | 7,567,900 | $703.5B | 18.76% | |
| 2 | BIIBBIOGEN INC | 727,024 | $148.3B | 3.95% | |
| 3 | CTKBCYTEK BIOSCIENCES INC | 13,381,054 | $143.6B | 3.83% | |
| 4 | AVTEAEROVATE THERAPEUTICS INC | 8,263,982 | $129.2B | 3.44% | |
| 5 | DAWNDAY ONE BIOPHARMACEUTICALS I | 7,040,622 | $126.0B | 3.36% | |
| 6 | TVTXTRAVERE THERAPEUTICS INC | 4,922,941 | $119.3B | 3.18% | |
| 7 | JANXJANUX THERAPEUTICS INC | 8,670,644 | $105.9B | 2.82% | |
| 8 | PCVXVAXCYTE INC | 4,581,203 | $99.7B | 2.66% | |
| 9 | IMGNEURIMMUNOGEN INC | 21,741,458 | $97.8B | 2.61% | |
| 10 | NKTXNKARTA INC | 7,805,129 | $96.2B | 2.56% | |
| 11 | BLUBELLUS HEALTH INC NEW | 10,230,274 | $94.5B | 2.52% | |
| 12 | 5E7ITEOS THERAPEUTICS INC | 4,417,259 | $91.0B | 2.43% | |
| 13 | VERUEURVERU INC | 7,900,000 | $89.3B | 2.38% | |
| 14 | —DICE THERAPEUTICS INC | 5,208,911 | $80.8B | 2.16% | |
| 15 | PEPGPEPGEN INC | 8,131,952 | $80.8B | 2.15% | |
| 16 | —FORMA THERAPEUTICS HLDGS INC | 9,011,651 | $62.1B | 1.66% | |
| 17 | ACRSACLARIS THERAPEUTICS INC | 4,398,453 | $61.4B | 1.64% | |
| 18 | —POINT BIOPHARMA GLOBAL INC | 9,003,018 | $61.3B | 1.63% | |
| 19 | TCE2CELLDEX THERAPEUTICS INC NEW | 2,075,000 | $55.9B | 1.49% | |
| 20 | WVEWAVE LIFE SCIENCES LTD | 17,202,009 | $55.9B | 1.49% | |
| 21 | VORVOR BIOPHARMA INC | 11,120,973 | $55.3B | 1.47% | |
| 22 | —KINNATE BIOPHARMA INC | 4,264,144 | $53.8B | 1.43% | |
| 23 | TYRATYRA BIOSCIENCES INC | 7,236,454 | $51.7B | 1.38% | |
| 24 | GHRSGH RESEARCH PLC | 4,898,373 | $48.9B | 1.30% | |
| 25 | GONGERON CORP | 30,126,299 | $46.7B | 1.25% | |
| 26 | NTRANATERA INC | 1,310,289 | $46.4B | 1.24% | |
| 27 | ABOSACUMEN PHARMACEUTICALS INC | 9,770,773 | $45.9B | 1.22% | |
| 28 | NSTGEURNANOSTRING TECHNOLOGIES | 3,584,478 | $45.5B | 1.21% | |
| 29 | RXSTRXSIGHT INC | 3,052,796 | $43.0B | 1.15% | |
| 30 | ENTAENANTA PHARMACEUTICALS INC | 896,724 | $42.4B | 1.13% | |
| 31 | CLYMELIEM THERAPEUTICS INC | 13,150,849 | $39.7B | 1.06% | |
| 32 | RLMDRELMADA THERAPEUTICS INC | 2,000,000 | $38.0B | 1.01% | |
| 33 | TILINSTIL BIO INC | 7,670,793 | $35.4B | 0.94% | |
| 34 | —ICOSAVAX INC | 5,963,565 | $34.2B | 0.91% | |
| 35 | RNAAVIDITY BIOSCIENCES INC | 2,167,391 | $31.5B | 0.84% | |
| 36 | DSGNDESIGN THERAPEUTICS INC | 2,186,636 | $30.6B | 0.82% | |
| 37 | ANTXAN2 THERAPEUTICS INC | 3,748,389 | $29.1B | 0.77% | |
| 38 | RCKTROCKET PHARMACEUTICALS INC | 2,107,149 | $29.0B | 0.77% | |
| 39 | EYPTEYEPOINT PHARMACEUTICALS INC | 3,370,506 | $26.5B | 0.71% | |
| 40 | ETNBGBP89BIO INC | 7,782,669 | $25.1B | 0.67% | |
| 41 | —SATSUMA PHARMACEUTICALS INC | 5,914,252 | $24.5B | 0.65% | |
| 42 | PMVPPMV PHARMACEUTICALS INC | 1,710,265 | $24.4B | 0.65% | |
| 43 | VERAVERA THERAPEUTICS INC | 1,578,820 | $21.5B | 0.57% | |
| 44 | VRNAVERONA PHARMA PLC | 5,100,000 | $21.4B | 0.57% | |
| 45 | RYTMRHYTHM PHARMACEUTICALS INC | 4,871,067 | $20.2B | 0.54% | |
| 46 | TNYATENAYA THERAPEUTICS INC | 3,551,508 | $20.0B | 0.53% | |
| 47 | DYNDYNE THERAPEUTICS INC | 2,805,045 | $19.3B | 0.51% | |
| 48 | HLVXHILLEVAX INC | 1,760,019 | $19.2B | 0.51% | |
| 49 | GHGUARDANT HEALTH INC | 476,380 | $19.2B | 0.51% | |
| 50 | —PARDES BIOSCIENCES INC | 6,175,038 | $19.0B | 0.51% | |
| 51 | HOWLWEREWOLF THERAPEUTICS INC | 4,291,881 | $17.6B | 0.47% | |
| 52 | —DA32 LIFE SCNCE | 1,500,000 | $14.5B | 0.39% | |
| 53 | CNCEEURCONCERT PHARMACEUTICALS INC | 3,307,203 | $13.9B | 0.37% | |
| 54 | MISTMILESTONE PHARMACEUTICALS IN | 2,246,503 | $13.8B | 0.37% | |
| 55 | 698ACHILLES THERAPEUTICS PLC | 5,014,687 | $12.6B | 0.34% | |
| 56 | —BCLS ACQUISITION CORP | 1,250,000 | $12.4B | 0.33% | |
| 57 | OTICEUROTONOMY INC | 5,600,000 | $11.6B | 0.31% | |
| 58 | LIANYLIANBIO | 4,622,574 | $10.0B | 0.27% | |
| 59 | —FRAZIER LIFESCIENCES ACQU CO | 1,000,000 | $9.9B | 0.26% | |
| 60 | —ARYA SCIENCES ACQUISITN | 1,000,000 | $9.7B | 0.26% | |
| 61 | RLAYRELAY THERAPEUTICS INC | 549,055 | $9.2B | 0.25% | |
| 62 | IOBTIO BIOTECH INC | 1,857,755 | $8.7B | 0.23% | |
| 63 | SLDBSOLID BIOSCIENCES INC | 12,367,873 | $7.6B | 0.20% | |
| 64 | —5 01 ACQUISITION CORP | 750,000 | $7.4B | 0.20% | |
| 65 | —SYNLOGIC INC | 5,825,858 | $6.7B | 0.18% | |
| 66 | BDTXBLACK DIAMOND THERAPEUTICS I | 2,589,904 | $6.4B | 0.17% | |
| 67 | IPSCCENTURY THERAPEUTICS INC | 756,821 | $6.4B | 0.17% | |
| 68 | —HEALTH SCIENCES ACQ CORP 2 | 625,000 | $6.2B | 0.17% | |
| 69 | CNTBCONNECT BIOPHARMA HLDGS LTD | 6,991,003 | $6.1B | 0.16% | |
| 70 | BMEABIOMEA FUSION INC | 500,000 | $6.0B | 0.16% | |
| 71 | —ATHIRA PHARMA INC | 1,878,000 | $5.7B | 0.15% | |
| 72 | XLOXILIO THERAPEUTICS INC | 1,649,711 | $4.8B | 0.13% | |
| 73 | WHWKAADI BIOSCIENCE INC | 383,028 | $4.7B | 0.13% | |
| 74 | FLBSTANDARD BIOTOOLS INC | 1,987,589 | $3.2B | 0.08% | |
| 75 | ENTXWENTERA BIO LTD | 2,353,000 | $3.1B | 0.08% | |
| 76 | TERNTERNS PHARMACEUTICALS INC | 1,261,435 | $3.1B | 0.08% | |
| 77 | BCABBIOATLA INC | 1,031,805 | $2.9B | 0.08% | |
| 78 | CATBUSDASTRIA THERAPEUTICS INC | 760,857 | $2.3B | 0.06% | |
| 79 | PYXSPYXIS ONCOLOGY INC | 953,393 | $2.3B | 0.06% | |
| 80 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 1,726,019 | $2.1B | 0.06% | |
| 81 | LRMRLARIMAR THERAPEUTICS INC | 1,031,482 | $2.0B | 0.05% | |
| 82 | ORTXUSDORCHARD THERAPEUTICS PLC | 3,040,885 | $1.8B | 0.05% | |
| 83 | CVRXCVRX INC | 275,000 | $1.7B | 0.04% | |
| 84 | SNSEEURSENSEI BIOTHERAPEUTICS | 723,549 | $1.6B | 0.04% | |
| 85 | OLMAOLEMA PHARMACEUTICALS INC | 233,793 | $952.0M | 0.03% | |
| 86 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 450,141 | $918.0M | 0.02% | |
| 87 | —AVROBIO INC | 559,600 | $515.0M | 0.01% | |
| 88 | —CALADRIUS BIOSCIENCES | 752,500 | $399.0M | 0.01% |